- Home
- BHFAN vs MIST Comparison
BHFAN vs MIST Comparison
Compare BHFAN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
BHFAN
Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C
Current Price
Company Overview
Basic Information| Metric | BHFAN | MIST |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 138.2M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BHFAN | MIST |
|---|---|---|
| Price | $11.14 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 58.6K | ★ 1.4M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.06 | N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $6,766,000,000.00 | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.93 | ★ N/A |
| Revenue Growth | ★ 43.23 | N/A |
| 52 Week Low | $10.95 | $1.00 |
| 52 Week High | $15.63 | $3.06 |
Technical Indicators
Market Signals| Indicator | BHFAN | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 23.42 | 42.04 |
| Support Level | $10.95 | $1.01 |
| Resistance Level | $11.76 | $1.42 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 1.35 | 30.36 |
Price Performance
Historical ComparisonAbout BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.